Myriad Genetics, Inc. (MYGN)
3.05
-0.15
(-4.69%)
USD |
NASDAQ |
Aug 24, 16:00
3.04
-0.01
(-0.33%)
After-Hours: 20:00
Myriad Genetics Total Assets (Quarterly) : 638.90M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 638.90M |
| March 31, 2026 | 673.70M |
| December 31, 2025 | 706.60M |
| September 30, 2025 | 728.10M |
| June 30, 2025 | 677.30M |
| March 31, 2025 | 1.006B |
| December 31, 2024 | 1.028B |
| September 30, 2024 | 1.081B |
| June 30, 2024 | 1.085B |
| March 31, 2024 | 1.110B |
| December 31, 2023 | 1.246B |
| September 30, 2023 | 1.149B |
| June 30, 2023 | 1.187B |
| March 31, 2023 | 1.169B |
| December 31, 2022 | 1.317B |
| September 30, 2022 | 1.212B |
| June 30, 2022 | 1.210B |
| March 31, 2022 | 1.255B |
| December 31, 2021 | 1.414B |
| September 30, 2021 | 1.336B |
| June 30, 2021 | 1.360B |
| March 31, 2021 | 1.337B |
| June 30, 2020 | 1.544B |
| March 31, 2020 | 1.447B |
| December 31, 2019 | 1.578B |
| Date | Value |
|---|---|
| September 30, 2019 | 1.591B |
| June 30, 2019 | 1.666B |
| March 31, 2019 | 1.557B |
| December 31, 2018 | 1.557B |
| September 30, 2018 | 1.574B |
| June 30, 2018 | 1.228B |
| March 31, 2018 | 1.218B |
| December 31, 2017 | 1.228B |
| September 30, 2017 | 1.228B |
| June 30, 2017 | 1.318B |
| March 31, 2017 | 1.268B |
| December 31, 2016 | 1.276B |
| September 30, 2016 | 1.271B |
| June 30, 2016 | 943.70M |
| March 31, 2016 | 868.20M |
| December 31, 2015 | 871.70M |
| September 30, 2015 | 787.00M |
| June 30, 2015 | 766.20M |
| March 31, 2015 | 779.05M |
| December 31, 2014 | 781.85M |
| September 30, 2014 | 809.01M |
| June 30, 2014 | 823.81M |
| March 31, 2014 | 816.43M |
| December 31, 2013 | 756.68M |
| September 30, 2013 | 781.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Natera, Inc. | 2.657B |
| Sera Prognostics, Inc. | 86.74M |
| BioRestorative Therapies, Inc. | 4.640M |
| CareDx, Inc. | 532.99M |
| Exagen, Inc. | 51.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 335.00M |
| Shareholders Equity (Quarterly) | 303.90M |
| Debt to Equity Ratio | 0.6927 |
| Current Ratio | 2.211 |
| Net Debt Paydown Yield | -1.94% |